We are live on ! Find out more
OH

Oikos Holdings Portfolio holdings

AUM $422M
1-Year Est. Return 13.79%
This Fund
S&P 500
This Quarter Est. Return
-9.75%
1 Year Est. Return
+13.79%
3 Year Est. Return
+5.54%
5 Year Est. Return
10 Year Est. Return
AUM
$164M
AUM Growth
+$37.7M
Cap. Flow
+$55.3M
Cap. Flow %
33.63%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
1
Reduced
1
Closed

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$1.81M

Sector Composition

Rank Sector Weight
1 Healthcare 71.76%
2 Financials 7.65%
3 Real Estate 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLNT
1
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$105M 64.12%
3,321,592
+1,575,700
+90% +$56.7M
FLOT icon
2
iShares Floating Rate Bond ETF
FLOT
$10B
$24.5M 14.89%
480,315
FG
3
DELISTED
FGL Holdings Ordinary Shares
FG
$12.6M 7.65%
1,500,000
SHPG
4
DELISTED
Shire pic
SHPG
$8.68M 5.27%
51,400
-11,250
-18% -$1.81M
KREF
5
KKR Real Estate Finance Trust
KREF
$489M
$4.56M 2.77%
230,391
BXMT icon
6
Blackstone Mortgage Trust
BXMT
$2.93B
$3.91M 2.38%
124,300
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
$3.07M 1.86%
24,700
FG.WS
8
DELISTED
FGL Holdings Warrants exercisable for one Ordinary Share at a price of $11.50 per share
FG.WS
$900K 0.55%
750,000
ZGNX
9
DELISTED
Zogenix, Inc.
ZGNX
$442K 0.27%
+10,000
New +$412K
VIRX
10
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$387K 0.24%
5,211

Similar funds

Oikos Holdings's Q2 2018 Portfolio in Review

As of Q2 2018, Oikos Holdings held 10 positions worth $164M, up 30% from $127M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Oikos Holdings deployed $55.3M of net new capital in Q2 2018, opening 1 new position and adding to 1 existing holding. Its largest new stake was Zogenix, Inc.: 10,000 shares worth $442K.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 61% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was Shire pic, an estimated $1.81M trimmed.

  • Oikos Holdings's largest Q2 2018 buy was Zogenix, Inc.: 10,000 shares worth $442K.
  • Oikos Holdings added most to Melinta Therapeutics, Inc. Common Stock in Q2 2018, an estimated $56.7M increase.
  • Oikos Holdings's biggest Q2 2018 reduction was Shire pic, cutting an estimated $1.81M.
  • Oikos Holdings's ten largest holdings make up 100% of its $164M portfolio in Q2 2018.
  • Oikos Holdings opened 1 new position and closed 0 in Q2 2018.
  • Oikos Holdings's portfolio value rose 30% quarter-over-quarter to $164M.

Based on Oikos Holdings's 13F filing for Q2 2018, filed 13 Aug 2018.